Vaccine ‘using inhaler could be ready by August’
Irish Mirror :
A vaccine for coronavirus could be ready in the form of an inhaler in just weeks, it is believed.
Researchers at University of Oxford are “80 per cent confident” the Covid-19 vaccine they’ve been developing will work, particularly on younger people.
Drug company Astra Zeneca will produce two billion doses of the vaccine when it gets the green light, it is reported on Tuesday. Professor Adrian Hill, of the university’s Centre for Personalised
Medicine, reportedly gave the new details in an online lecture this week. He said: “We are guessing that might be around about August time – it might be before if cases do not decline as quickly as we expect, or be later if we run out of cases.” He added the drug will be in the form of an inhaler, it is understood.
The trial, which started in April, began recruiting up to 10,260 adults over 55 and children.
Since then, Astra Zeneca has already agreed to supply 100 million doses of the potential vaccine to the UK. The Anglo-Swedish company has also signed a massive $1 billion deal for a coronavirus vaccine with the US government. But the coronavirus drug is still undergoing trials at the university’s Jenner Institute, which is working with the Oxford Vaccine Group on the project.
Currently, there is no vaccine or treatment available for Covid-19 but doctors across the globe are testing current anti-viral drugs to see if they can beat coronavirus.
A vaccine for coronavirus could be ready in the form of an inhaler in just weeks, it is believed.
Researchers at University of Oxford are “80 per cent confident” the Covid-19 vaccine they’ve been developing will work, particularly on younger people.
Drug company Astra Zeneca will produce two billion doses of the vaccine when it gets the green light, it is reported on Tuesday. Professor Adrian Hill, of the university’s Centre for Personalised
Medicine, reportedly gave the new details in an online lecture this week. He said: “We are guessing that might be around about August time – it might be before if cases do not decline as quickly as we expect, or be later if we run out of cases.” He added the drug will be in the form of an inhaler, it is understood.
The trial, which started in April, began recruiting up to 10,260 adults over 55 and children.
Since then, Astra Zeneca has already agreed to supply 100 million doses of the potential vaccine to the UK. The Anglo-Swedish company has also signed a massive $1 billion deal for a coronavirus vaccine with the US government. But the coronavirus drug is still undergoing trials at the university’s Jenner Institute, which is working with the Oxford Vaccine Group on the project.
Currently, there is no vaccine or treatment available for Covid-19 but doctors across the globe are testing current anti-viral drugs to see if they can beat coronavirus.
